Published in J Biol Chem on August 08, 2001
GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci (2003) 10.89
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol (2006) 3.17
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem (2003) 2.15
GSK-3: Functional Insights from Cell Biology and Animal Models. Front Mol Neurosci (2011) 1.99
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci U S A (2002) 1.96
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets (2006) 1.78
Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther (2014) 1.77
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J Virol (2003) 1.62
GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget (2014) 1.56
Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J Biol Chem (2003) 1.56
Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis. J Biol Chem (2007) 1.46
Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J (2009) 1.42
Subcellular localization of glycogen synthase kinase 3beta controls embryonic stem cell self-renewal. Mol Cell Biol (2009) 1.31
Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res (2009) 1.29
Regulation of the Arabidopsis GSK3-like kinase BRASSINOSTEROID-INSENSITIVE 2 through proteasome-mediated protein degradation. Mol Plant (2008) 1.29
Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab (2008) 1.28
Deconstructing GSK-3: The Fine Regulation of Its Activity. Int J Alzheimers Dis (2011) 1.22
Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia (2013) 1.22
GSK-3β: A Bifunctional Role in Cell Death Pathways. Int J Cell Biol (2012) 1.21
Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1. FEBS Lett (2006) 1.19
Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition. J Biol Chem (2003) 1.16
Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells. Mol Cell Biol (2004) 1.15
Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons. PLoS One (2009) 1.09
NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3. Carcinogenesis (2010) 1.02
AMP-activated protein kinase restricts IFN-γ signaling. J Immunol (2012) 1.01
Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J Virol (2005) 1.01
p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle (2013) 1.00
Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J Biol Chem (2008) 0.99
Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts. Aging Cell (2004) 0.98
Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins. J Mol Cell Cardiol (2006) 0.98
Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18. Nucleic Acids Res (2006) 0.97
Phosphorylation of neuronal survival factor MEF2D by glycogen synthase kinase 3beta in neuronal apoptosis. J Biol Chem (2009) 0.96
Association of glycogen synthase kinase-3β with Parkinson's disease (review). Mol Med Rep (2014) 0.94
Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain. PLoS One (2010) 0.92
The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death. Mol Cell Biol (2008) 0.92
Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress. J Biol Chem (2013) 0.91
Modelling the role of the Hsp70/Hsp90 system in the maintenance of protein homeostasis. PLoS One (2011) 0.91
GSK-3 Mouse Models to Study Neuronal Apoptosis and Neurodegeneration. Front Mol Neurosci (2011) 0.88
Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis. Oncogene (2011) 0.87
Differential responses of pancreatic β-cells to ROS and RNS. Am J Physiol Endocrinol Metab (2013) 0.87
GSK3 and p53 - is there a link in Alzheimer's disease? Mol Neurodegener (2010) 0.86
Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency. Neurotox Res (2008) 0.85
Bacillus anthracis edema toxin activates nuclear glycogen synthase kinase 3beta. Infect Immun (2008) 0.85
Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging. Theranostics (2016) 0.84
Glycogen synthase kinase 3beta induces apoptosis in cancer cells through increase of survivin nuclear localization. Cancer Lett (2008) 0.84
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death. BMC Cancer (2010) 0.84
Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta (2013) 0.84
HSP105 interacts with GRP78 and GSK3 and promotes ER stress-induced caspase-3 activation. Cell Signal (2007) 0.83
Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells. Biol Direct (2011) 0.82
ATF3 Mediates Anti-Cancer Activity of Trans-10, cis-12-Conjugated Linoleic Acid in Human Colon Cancer Cells. Biomol Ther (Seoul) (2015) 0.80
Adhesion-dependent redistribution of MAP kinase and MEK promotes muscarinic receptor-mediated signaling to the nucleus. J Cell Biochem (2005) 0.80
Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury. J Biol Chem (2014) 0.80
Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functions. PLoS One (2012) 0.79
Brief review of the role of glycogen synthase kinase-3β in amyotrophic lateral sclerosis. Neurol Res Int (2011) 0.78
Protein kinase R-like endoplasmic reticulum kinase and glycogen synthase kinase-3α/β regulate foam cell formation. J Lipid Res (2014) 0.78
Exercise training enhanced the expression of myocardial proteins related to cell protection in spontaneously hypertensive rats. Pflugers Arch (2004) 0.78
Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson's Disease. Front Physiol (2012) 0.77
Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin. PLoS One (2013) 0.76
Plant Natural Product Formononetin Protects Rat Cardiomyocyte H9c2 Cells against Oxygen Glucose Deprivation and Reoxygenation via Inhibiting ROS Formation and Promoting GSK-3β Phosphorylation. Oxid Med Cell Longev (2016) 0.75
Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1. Exp Cell Res (2013) 0.75
Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia. PLoS One (2015) 0.75
Novel Non-phosphorylated Serine 9/21 GSK3β/α Antibodies: Expanding the Tools for Studying GSK3 Regulation. Front Mol Neurosci (2016) 0.75
Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex. Brain Res (2016) 0.75
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1996) 26.30
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol (1997) 15.32
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev (1998) 12.55
A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A (1996) 11.37
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell (1991) 6.89
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol (2001) 6.12
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res (1998) 6.11
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J (1993) 5.60
Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem (1998) 5.09
Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science (1997) 4.99
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A (2000) 3.61
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J (1993) 3.51
Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci (2000) 2.70
Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem (1992) 2.57
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol (2000) 2.40
Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem (1994) 2.38
Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci U S A (2000) 2.34
Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem (2000) 1.98
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A (1993) 1.92
Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol (2000) 1.84
Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase. Eur J Biochem (1981) 1.63
Glycogen synthase kinase 3beta and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock. Mol Cell Biol (1998) 1.55
HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem (1999) 1.53
Glycogen synthase kinase 3beta negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1. J Biol Chem (2000) 1.53
Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem (1999) 1.52
Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge. Biochemistry (1998) 1.45
Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway. J Biol Chem (1999) 1.38
Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem (2000) 1.29
Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem (2000) 1.26
Heat shock effects on cell cycle progression. Cell Mol Life Sci (2000) 1.23
Phosphorylation of the nuclear transport machinery down-regulates nuclear protein import in vitro. J Biol Chem (2000) 1.10
Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J Neurochem (1997) 1.02
Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells. J Neurochem (1999) 0.87
Nuclear glycogen and glycogen synthase kinase 3. Biochem Biophys Res Commun (1998) 0.79
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol (2001) 6.12
Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell (1997) 2.13
CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem (2001) 2.11
Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem (2000) 1.98
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry (2011) 1.86
Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat Med (1999) 1.73
Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem (1999) 1.52
Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ (2008) 1.46
Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res (2001) 1.30
Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem (2000) 1.26
The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res (1992) 1.17
High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res (1979) 1.16
Biochemical effects of phosphatidylcholine treatment in rats. Biochem Pharmacol (1984) 1.08
Proteolysis of tau by calpain. Biochem Biophys Res Commun (1989) 1.04
Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity (1995) 1.03
Choline accumulates in erythrocytes during lithium therapy. N Engl J Med (1978) 1.03
Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. J Neural Transm (Vienna) (1999) 1.00
Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol (1987) 0.97
Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J Neurochem (1991) 0.96
Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp Neurol (1989) 0.94
Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells. Arch Biochem Biophys (2001) 0.92
Phosphoinositide signaling in human brain. Prog Neurobiol (1996) 0.92
Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging (2000) 0.91
Muscarinic receptor stimulation increases regulators of G-protein signaling 2 mRNA levels through a protein kinase C-dependent mechanism. J Biol Chem (1999) 0.91
Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain. Neurobiol Aging (1996) 0.91
Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol (1986) 0.90
Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neuroscience (2010) 0.90
Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3. Neuroscience (2012) 0.90
Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. Genes Brain Behav (2013) 0.88
Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res (1996) 0.88
Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. J Neurosci (1996) 0.88
Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells. Biochem J (1998) 0.87
Muscarinic M3 and epidermal growth factor receptors activate mutually inhibitory signaling cascades in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun (1999) 0.87
Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport (1999) 0.86
Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling. Biochem J (1999) 0.86
Pertussis toxin-sensitive G protein alpha-subunits: production of monoclonal antibodies and detection of differential increases on differentiation of PC12 and LA-N-5 cells. J Neurochem (1995) 0.86
Metabolic effects of nicotinamide administration in rats. J Nutr (1983) 0.86
Erythrocyte choline concentrations are elevated in manic patients. Proc Natl Acad Sci U S A (1980) 0.86
The interrelationship between selective tau phosphorylation and microtubule association. Brain Res (1998) 0.86
Inhibition of NFkB DNA binding activity by glucocorticoids in rat brain. Neurosci Lett (1995) 0.85
Further evidence for a muscarinic component to the neural vasodilator innervation of cerebral and cranial extracerebral arteries of the cat. Circ Res (1982) 0.85
Aluminum impairs glucose utilization and cholinergic activity in rat brain in vitro. Toxicology (1986) 0.84
Second messengers regulate RGS2 expression which is targeted to the nucleus. Biochim Biophys Acta (2001) 0.84
Regulation of acetylcholine synthesis: does cytoplasmic acetylcholine control high affinity choline uptake? Science (1976) 0.84
Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine. J Neurochem (1987) 0.84
A mechanism for the accumulation of choline in erythrocytes during treatment with lithium. Commun Psychopharmacol (1980) 0.84
RGS2: regulation of expression and nuclear localization. Biochem Biophys Res Commun (2001) 0.84
Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo. Brain Res Mol Brain Res (1997) 0.83
G-proteins modulate amiloride-sensitive sodium channels. J Biol Chem (1994) 0.83
Acetylcholine turnover and compartmentation in rat brain synaptosomes. J Neurochem (1981) 0.83
Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells. J Neurochem (1999) 0.83
Brain amino acid concentrations in rats killed by decapitation and microwave irradiation. J Neurosci Methods (1990) 0.82
Comparison of [3H]phosphatidylinositol and [3H]phosphatidylinositol 4,5-bisphosphate hydrolysis in postmortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J Neurochem (1997) 0.82
Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. J Neurosci Res (1979) 0.82
Synaptosomal transport and acetylation of choline. Life Sci (1977) 0.82
Phosphorylation of rat brain cytoskeletal proteins is increased after orally administered aluminum. Brain Res (1988) 0.82
Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices. Mol Pharmacol (1986) 0.81
Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid. Exp Neurol (1987) 0.81
Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience (1995) 0.81
Oral aluminum alters in vitro protein phosphorylation and kinase activities in rat brain. Neurobiol Aging (1990) 0.81
Modulation of endogenous ADP-ribosylation in rat brain. Brain Res (1992) 0.81
Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res Mol Brain Res (1999) 0.81
Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats. Brain Res (1995) 0.81
Effect of pretreatment under various cationic conditions on acetylcholine content and choline transport in rat whole brain synaptosomes. J Neurochem (1978) 0.80
Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids. Brain Res Mol Brain Res (1995) 0.80
Determination of inositol phosphates and other anions in rat brain. J Chromatogr Sci (1989) 0.80
Reduced Ca2+ flux in synaptosomes from cats with GM1 gangliosidosis. Brain Res (1987) 0.80
Analysis of the convulsant-potentiating effects of lithium in rats. Exp Neurol (1991) 0.80
Regulation of acetylcholine synthesis: control of choline transport and acetylation in synaptosomes. J Neurochem (1978) 0.80
Neurochemical consequences of status epilepticus induced in rats by coadministration of lithium and pilocarpine. Exp Neurol (1986) 0.80
Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem (1992) 0.80
Dietary aluminum selectively decreases MAP-2 in brains of developing and adult rats. Neurotoxicology (1992) 0.79
The utilization of choline and acetyl coenzyme A for the synthesis of acetylcholine. J Neurochem (1980) 0.79
Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Brain Res Mol Brain Res (1994) 0.79
Aluminum inhibits the fast phase of voltage-dependent calcium influx into synaptosomes. J Neurochem (1987) 0.79
Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells. Neurobiol Aging (2000) 0.78
Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J Neurochem (1995) 0.78
Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease. J Am Geriatr Soc (1990) 0.78
Brain G-protein proteolysis by calpain: enhancement by lithium. Brain Res (1994) 0.78
Modulation of carbachol-stimulated inositol phospholipid hydrolysis in rat cerebral cortex. Neurochem Res (1987) 0.78
Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry (1991) 0.78
Dimethylaminoethanol (deanol) metabolism in rat brain and its effect on acetylcholine synthesis. J Pharmacol Exp Ther (1979) 0.77
Effects of phosphatidylcholine administration to rats on choline in blood and choline and acetylcholine in brain. J Pharmacol Exp Ther (1982) 0.77
Formation of triple-stranded bovine DNA in vitro. Nature (1975) 0.77
Increased metabolism of acetylcholine in brain of cats with Gm1 gangliosidosis. Brain Res (1985) 0.77
Cholinergic processes in blood samples from patients with major psychiatric disorders. Biol Psychiatry (1985) 0.77
Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-D-aspartate. Brain Res (1991) 0.77
Src family kinase involvement in muscarinic receptor-induced tyrosine phosphorylation in differentiated SH-SY5Y cells. Neurochem Res (2001) 0.77
Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1. Brain Res (2001) 0.77
Increased acetylcholine synthesis and release in brains of cats with GM1 gangliosidosis. J Neurochem (1986) 0.76
Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Brain Res Mol Brain Res (1994) 0.76
Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex. Eur J Pharmacol (1987) 0.76
Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res (1987) 0.76
Protein synthesis inhibitors attenuate seizures induced in rats by lithium plus pilocarpine. Exp Neurol (1994) 0.76
Free and bound choline blood levels after phosphatidylcholine. Clin Pharmacol Ther (1982) 0.76
Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res (1999) 0.75
Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology (Berl) (1995) 0.75
Alpha-1 adrenergic receptor binding and adrenergic-stimulated cyclic AMP production in rat cerebral cortex after chronic lithium treatment. J Neural Transm Gen Sect (1990) 0.75
Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo. Neuroreport (1994) 0.75
Inhibition of receptor-coupled phosphoinositide hydrolysis by sulfur-containing amino acids in rat brain slices. Biochem Pharmacol (1989) 0.75